COLOPLAST-B (CBHD.DE) Stock Price, Forecast & Analysis

FRA:CBHD • DK0060448595

65.38 EUR
+0.9 (+1.4%)
Last: Feb 27, 2026, 07:00 PM

CBHD.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap13.74B
Revenue(TTM)27.89B
Net Income(TTM)3.99B
Shares210.20M
Float144.72M
52 Week High104.95
52 Week Low63.06
Yearly Dividend2.94
Dividend Yield4.78%
EPS(TTM)2.55
PE25.64
Fwd PE17
Earnings (Next)05-12
IPO1983-01-01
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies
CBHD.DE short term performance overview.The bars show the price performance of CBHD.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15 -20

CBHD.DE long term performance overview.The bars show the price performance of CBHD.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of CBHD.DE is 65.38 EUR. In the past month the price decreased by -9.37%. In the past year, price decreased by -36.37%.

COLOPLAST-B / CBHD Daily stock chart

CBHD.DE Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
CBHD.DE Full Technical Analysis Report

CBHD.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to CBHD.DE. CBHD.DE has an excellent profitability rating, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
CBHD.DE Full Fundamental Analysis Report

CBHD.DE Financial Highlights

Over the last trailing twelve months CBHD.DE reported a non-GAAP Earnings per Share(EPS) of 2.55. The EPS decreased by -13.16% compared to the year before.


Industry RankSector Rank
PM (TTM) 14.3%
ROA 8.17%
ROE 28.9%
Debt/Equity 1.55
Chartmill High Growth Momentum
EPS Q2Q%26.79%
Sales Q2Q%0.24%
EPS 1Y (TTM)-13.16%
Revenue 1Y (TTM)1.61%
CBHD.DE financials

CBHD.DE Forecast & Estimates

27 analysts have analysed CBHD.DE and the average price target is 77.93 EUR. This implies a price increase of 19.19% is expected in the next year compared to the current price of 65.38.

For the next year, analysts expect an EPS growth of 46.9% and a revenue growth 3.82% for CBHD.DE


Analysts
Analysts69.63
Price Target77.93 (19.2%)
EPS Next Y46.9%
Revenue Next Year3.82%
CBHD.DE Analyst EstimatesCBHD.DE Analyst Ratings

CBHD.DE Ownership

Ownership
Inst Owners28.86%
Ins Owners29.79%
Short Float %N/A
Short RatioN/A
CBHD.DE Ownership

About CBHD.DE

Company Profile

CBHD logo image Coloplast A/S engages in the developing, manufacture, and markets medical products. The company is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The firm supplies products to hospitals, institutions as well as wholesalers and pharmacies.

Company Info

COLOPLAST-B

Holtedam 1-3

Humlebaek DK

Employees: 16628

CBHD Company Website

CBHD Investor Relations

Phone: 4549111111

COLOPLAST-B / CBHD.DE FAQ

What does COLOPLAST-B do?

Coloplast A/S engages in the developing, manufacture, and markets medical products. The company is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The firm supplies products to hospitals, institutions as well as wholesalers and pharmacies.


Can you provide the latest stock price for COLOPLAST-B?

The current stock price of CBHD.DE is 65.38 EUR. The price increased by 1.4% in the last trading session.


What is the dividend status of COLOPLAST-B?

COLOPLAST-B (CBHD.DE) has a dividend yield of 4.78%. The yearly dividend amount is currently 2.94.


What is the ChartMill technical and fundamental rating of CBHD stock?

CBHD.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


How is the market expecting CBHD stock to perform?

27 analysts have analysed CBHD.DE and the average price target is 77.93 EUR. This implies a price increase of 19.19% is expected in the next year compared to the current price of 65.38.


Can you provide the PE ratio for CBHD stock?

The PE ratio for COLOPLAST-B (CBHD.DE) is 25.64. This is based on the reported non-GAAP earnings per share of 2.55 and the current share price of 65.38 EUR.